Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoprotein.
Abstract Mildly oxidized low density lipoprotein (mLDL) acutely increases the permeability of the vascular endothelium to molecules that would not otherwise cross the barrier. This study has shown that ascorbic acid tightens the permeability barrier in the endothelial barrier in cells, so this work tested whether it might prevent the increase in endothelial permeability due to mLDL. Treatment of EA.hy926 endothelial cells with mLDL decreased intracellular GSH and activated the cells to further oxidize the mLDL. mLDL also increased endothelial permeability over 2 h to both inulin and ascorbate in cells cultured on semi-permeable filters. This effect was blocked by microtubule and microfilament inhibitors, but not by chelation of intracellular calcium. Intracellular ascorbate both prevented and reversed the mLDL-induced increase in endothelial permeability, an effect mimicked by other cell-penetrant antioxidants. These results suggest a role for endothelial cell ascorbate in ameliorating an important facet of endothelial dysfunction caused by mLDL.
May
James M
JM
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-0475, USA. james.may@vanderbilt.edu
Qu
Zhi-Chao
ZC
D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects*; D002460:Cell Line; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects
D000975:Antioxidants; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D001205:Ascorbic Acid
J Cell Physiol. 1995 May;163(2):393-9
7706381
J Cell Physiol. 1987 Jul;132(1):111-7
3597548
Arch Biochem Biophys. 2005 Feb 1;434(1):178-86
15629121
Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1583-90
9301639
Cardiovasc Res. 2009 May 1;82(2):371-81
19176597
Circ Res. 1997 Jan;80(1):37-44
8978320
N Engl J Med. 1989 Apr 6;320(14):915-24
2648148
J Biol Chem. 1999 Oct 22;274(43):30361-4
10521411
Mol Cell Biochem. 2008 Feb;309(1-2):125-32
18026819
J Cell Physiol. 1996 Jun;167(3):562-9
8655610
Am J Physiol Cell Physiol. 2009 Jul;297(1):C169-78
19419995
Arch Biochem Biophys. 1998 Jan 15;349(2):281-9
9448716
Free Radic Biol Med. 2009 Apr 15;46(8):1049-57
19185609
Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2305-11
7489257
Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1575-82
9301638
Free Radic Biol Med. 1999 Sep;27(5-6):667-72
10490287
Biochem Pharmacol. 2001 Oct 1;62(7):873-81
11543722
Free Radic Biol Med. 2002 Jul 1;33(1):83-93
12086686
Free Radic Biol Med. 1995 Aug;19(2):177-87
7649489
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
J Biol Chem. 1998 Aug 21;273(34):21867-74
9705325
FEBS Lett. 1992 Mar 24;299(1):60-5
1544476
Anal Biochem. 1976 Jul;74(1):214-26
962076
Circ Res. 2007 May 11;100(9):1337-43
17446432
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6931-6
10359816
J Neurochem. 1997 Mar;68(3):991-1000
9048744
Eur J Clin Invest. 1997 Jan;27(1):48-54
9041377
FEBS Lett. 2010 Jan 4;584(1):61-6
19944695
Arch Biochem Biophys. 2009 May 15;485(2):174-82
19254685
Am J Physiol Cell Physiol. 2001 Apr;280(4):C719-41
11245588
Mol Cell Biochem. 2009 May;325(1-2):79-88
19148707
Biochem Pharmacol. 1994 May 18;47(10):1725-30
8204089
J Cell Biol. 2007 Feb 26;176(5):719-27
17312022
J Cell Physiol. 1992 Dec;153(3):437-49
1280276
Microvasc Res. 2004 Nov;68(3):231-8
15501242
Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883-7
6587396
Experientia. 1996 Mar 15;52(3):234-8
8631392
Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):81-91
7779579
Am J Hematol. 1995 Jul;49(3):250-2
7604820
J Biol Chem. 1970 Mar 25;245(6):1374-7
5462997